Ranbaxy Laboratories, India’s biggest drug maker by revenue, said it expects sales to increase by at least 10 per cent in 2012 as it takes advantage of expiring drug patents in the United States, its biggest market. Ranbaxy, which launched a generic version of cholesterol drug Lipitor in the US market in December, reported a fourth-quarter loss equivalent to $606 million. Sales, however, soared 79.2 per cent to $759.37 million in the quarter to Dec.31 from a year earlier, and were up 16.6 per cent at $2.02 billion for the full year.
GMT 12:09 2018 Monday ,26 November
Black Friday less wild as more Americans turn to online dealsGMT 15:06 2018 Sunday ,18 November
Refugee host countries discuss UNRWA's financial crisisGMT 16:17 2018 Monday ,12 November
Egypt working on 4-year plan to increase growth rateGMT 12:45 2018 Friday ,09 November
Egyptian agriculture products introduced to Japanese markeGMT 11:42 2018 Friday ,02 November
Turkey's new mega airport, boon for slowing economyGMT 13:42 2018 Monday ,29 October
Egypt's trade volume hits $67.63 bln over 9 monthsGMT 15:13 2018 Friday ,12 October
Govt to announce incentives package for Overseas PakistanisGMT 14:46 2018 Thursday ,11 October
Economy and energy dominate agenda in Russian-Slovak relationsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor